Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 CNS 3 Sarcoma 1 Head & Neck 1 Endocrine 1

Conditions

Interventions

Magnetic Resonance Spectroscopy 13 Ifosfamide 12 Doxorubicin 12 Blood Specimen Collection 12 Radiotherapy 11 Methotrexate 10 fludarabine phosphate 9 Surgical Procedures, Operative 9 Radiosurgery 9 Cyclophosphamide 9 Surveys and Questionnaires 8 Cyclosporine 8 Proton Therapy 7 Peripheral Blood Stem Cell Transplantation 7 Busulfan 7 Mycophenolic Acid 6 Melphalan 6 Whole-Body Irradiation 5 Standard of Care 5 Filgrastim 5 Etoposide 5 Early Intervention, Educational 5 Carboplatin 5 Biopsy 5 Antilymphocyte Serum 5 Vincristine 4 Temozolomide 4 Sunitinib 4 Radiation Dose Hypofractionation 4 Mesna 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Ferrosoferric Oxide × Sarcoma × Clear all

NCT01663090 2020-10-19

Ferumoxytol-Enhanced MRI in Adult/Pedi Sarcomas

Dana-Farber Cancer Institute

Phase NA Withdrawn

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡